Thomas D. Carey Standard Biotools Inc. (LAB) insider trading activity

LAB Quotes by TradingView

Thomas D. Carey is of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 194,058 shares of LAB, which is worth approximately $261,978. The most recent transaction as insider was on Jun 20, 2025, when has been sold 94,592 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 194K
95.1% 3M change
349.96% 12M change
Total Value Held $261,978

Thomas D. Carey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Grant, award, or other acquisition
-
94,592 Added 32.77%
194,058 Common Stock
Feb 28 2025
BUY
Grant, award, or other acquisition
$59,718 $1.06 p/Share
56,338 Added 36.16%
99,466 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
-
43,128 Added 50.0%
43,128 Common Stock
Jan 05 2024
BUY
Grant, award, or other acquisition
-
79,412 Added 50.0%
79,412 Common Stock

Also insider at

EXAS
EXACT SCIENCES CORP Healthcare
Director
SLGC
SomaLogic, Inc. Healthcare
Director
TDC

Thomas D. Carey

Madison, WI

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LAB